Contenu disponible en anglais seulement.
Négociation suspendue de la TSX - Acerus Pharmaceuticals Corporation (ASP)
26 janvier 2023
| Issuer: | Acerus Pharmaceuticals Corporation |
| Security: | Common Shares (the "Shares") |
| Symbol(s): | ASP |
| Delisting Review Type: | Expedited |
| Reason: | TSX is reviewing the Shares with respect to meeting the requirements for continued listing pursuant to the Expedited Review Process. |
| Trading: | The Shares are suspended from trading immediately. |
| TSX contact: | Selma Thaver, Director, TSX Listings |